Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

G. Curigliano; M.J. Cardoso; P. Poortmans; O. Gentilini; G. Pravettoni; K. Mazzocco; N. Houssami; O. Pagani; E. Senkus; F. Cardoso

doi:10.1016/j.breast.2020.04.006

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

G. Curigliano, M.J. Cardoso, P. Poortmans, O. Gentilini, G. Pravettoni, K. Mazzocco, N. Houssami, O. Pagani, E. Senkus, F. Cardoso

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments. © 2020 The Author(s)

Original language	English
Pages (from-to)	8-16
Number of pages	9
Journal	Breast
Volume	52
DOIs	https://doi.org/10.1016/j.breast.2020.04.006
Publication status	Published - 2020

Keywords

advanced cancer
Article
breast cancer
breast reconstruction
cancer growth
cancer patient
cancer radiotherapy
cancer recurrence
cancer risk
cancer screening
cancer surgery
cancer therapy
coronavirus disease 2019
Coronavirus infection
decision making
early cancer
emergency health service
feasibility study
follow up
health care concepts
health care facility
hospitalization
human
population research
practice guideline
prioritization
priority journal
public health
Severe acute respiratory syndrome coronavirus 2
Betacoronavirus
breast tumor
cancer center
health care delivery
pandemic
procedures
risk assessment
virus pneumonia
Breast Neoplasms
Coronavirus Infections
COVID-19
Delivery of Health Care
Humans
Oncology Service, Hospital
Pandemics
Pneumonia, Viral
Practice Guidelines as Topic
Risk Assessment
SARS-CoV-2
Triage

Access to Document

10.1016/j.breast.2020.04.006

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083451312&doi=10.1016%2fj.breast.2020.04.006&partnerID=40&md5=928c8678968da877637101542aef580d

Cite this

@article{0d2c899d272f4bf8aaecf6a33a9132b3,

title = "Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic",

abstract = "The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments. {\textcopyright} 2020 The Author(s)",

keywords = "advanced cancer, Article, breast cancer, breast reconstruction, cancer growth, cancer patient, cancer radiotherapy, cancer recurrence, cancer risk, cancer screening, cancer surgery, cancer therapy, coronavirus disease 2019, Coronavirus infection, decision making, early cancer, emergency health service, feasibility study, follow up, health care concepts, health care facility, hospitalization, human, population research, practice guideline, prioritization, priority journal, public health, Severe acute respiratory syndrome coronavirus 2, Betacoronavirus, breast tumor, cancer center, health care delivery, pandemic, procedures, risk assessment, virus pneumonia, Breast Neoplasms, Coronavirus Infections, COVID-19, Delivery of Health Care, Humans, Oncology Service, Hospital, Pandemics, Pneumonia, Viral, Practice Guidelines as Topic, Risk Assessment, SARS-CoV-2, Triage",

author = "G. Curigliano and M.J. Cardoso and P. Poortmans and O. Gentilini and G. Pravettoni and K. Mazzocco and N. Houssami and O. Pagani and E. Senkus and F. Cardoso",

note = "Cited By :66 Export Date: 11 March 2021 CODEN: BREAE Correspondence Address: Curigliano, G.; Division of Early Drug Development for Innovative Therapies, Via Giuseppe Ripamonti n. 435, Italy; email: giuseppe.curigliano@ieo.it Funding details: Pfizer Funding details: Roche Italia Funding details: National Breast Cancer Foundation, NBCF Funding text 1: GC reports grants from Roche, advisory role for Daichii Sankyo, Astra Zeneca Macrogenics, BMS and Ellipsis, personal fees from MSD, Astra Zeneca, travel grants from Pfizer, personal fees from Daichii Sankyo, outside the submitted work; Funding text 2: NH receives funding via a National Breast Cancer Foundation (NBCF Australia) Breast Cancer Research Leadership Fellowship.",

year = "2020",

doi = "10.1016/j.breast.2020.04.006",

language = "English",

volume = "52",

pages = "8--16",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

AU - Curigliano, G.

AU - Cardoso, M.J.

AU - Poortmans, P.

AU - Gentilini, O.

AU - Pravettoni, G.

AU - Mazzocco, K.

AU - Houssami, N.

AU - Pagani, O.

AU - Senkus, E.

AU - Cardoso, F.

N1 - Cited By :66 Export Date: 11 March 2021 CODEN: BREAE Correspondence Address: Curigliano, G.; Division of Early Drug Development for Innovative Therapies, Via Giuseppe Ripamonti n. 435, Italy; email: giuseppe.curigliano@ieo.it Funding details: Pfizer Funding details: Roche Italia Funding details: National Breast Cancer Foundation, NBCF Funding text 1: GC reports grants from Roche, advisory role for Daichii Sankyo, Astra Zeneca Macrogenics, BMS and Ellipsis, personal fees from MSD, Astra Zeneca, travel grants from Pfizer, personal fees from Daichii Sankyo, outside the submitted work; Funding text 2: NH receives funding via a National Breast Cancer Foundation (NBCF Australia) Breast Cancer Research Leadership Fellowship.

PY - 2020

Y1 - 2020

N2 - The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments. © 2020 The Author(s)

AB - The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments. © 2020 The Author(s)

KW - advanced cancer

KW - Article

KW - breast cancer

KW - breast reconstruction

KW - cancer growth

KW - cancer patient

KW - cancer radiotherapy

KW - cancer recurrence

KW - cancer risk

KW - cancer screening

KW - cancer surgery

KW - cancer therapy

KW - coronavirus disease 2019

KW - Coronavirus infection

KW - decision making

KW - early cancer

KW - emergency health service

KW - feasibility study

KW - follow up

KW - health care concepts

KW - health care facility

KW - hospitalization

KW - human

KW - population research

KW - practice guideline

KW - prioritization

KW - priority journal

KW - public health

KW - Severe acute respiratory syndrome coronavirus 2

KW - Betacoronavirus

KW - breast tumor

KW - cancer center

KW - health care delivery

KW - pandemic

KW - procedures

KW - risk assessment

KW - virus pneumonia

KW - Breast Neoplasms

KW - Coronavirus Infections

KW - COVID-19

KW - Delivery of Health Care

KW - Humans

KW - Oncology Service, Hospital

KW - Pandemics

KW - Pneumonia, Viral

KW - Practice Guidelines as Topic

KW - Risk Assessment

KW - SARS-CoV-2

KW - Triage

U2 - 10.1016/j.breast.2020.04.006

DO - 10.1016/j.breast.2020.04.006

M3 - Article

VL - 52

SP - 8

EP - 16

JO - Breast

JF - Breast

SN - 0960-9776

ER -

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

Abstract

Keywords

Access to Document

Fingerprint

Cite this